Forest Settles With Spitzer; Trial Registry Will Focus On Phase III-IV

Forest Labs' settlement agreement with New York Attorney General Eliot Spitzer requires less disclosure of clinical data than an earlier settlement between Spitzer and GlaxoSmithKline